AFP and hepatocellular carcinoma: More importantly, IL-35 robustly dampened IFN-γ secretion by AFP-specific liver-resident CD8+ T cells purified from both non-tumor and tumor site, further revealing the immunosuppressive characteristic of IL-35 to CD8+ T cells in non-viral hepatitis-related HCC.